Winton Group LTD Corbus Pharmaceuticals Holdings, Inc. Transaction History

Winton Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Jul 21, 2021	SELL	$1.27 - $3.42 $59,364 - $159,864	-46,744 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$0.94 - $1.89 $43,939 - $88,346	46,744 New	46,744 $58,000
Q3 2019 Nov 08, 2019	SELL	$4.87 - $7.08 $68,053 - $98,935	-13,974 Closed	0 $0
Q2 2019 Jul 08, 2019	BUY	$6.6 - $7.8 $92,228 - $108,997	13,974 New	13,974 $97,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.